Page last updated: 2024-10-26

etanidazole and Eye Cancer, Retinoblastoma

etanidazole has been researched along with Eye Cancer, Retinoblastoma in 1 studies

Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rootman, J1
Gallie, B1
Kumi, C1
Bussanich, N1
Rogers, B1
Palcic, B1

Other Studies

1 other study available for etanidazole and Eye Cancer, Retinoblastoma

ArticleYear
Ocular penetration, toxicity, and radiosensitization effects of two hypoxic cell radiosensitizers on retinoblastoma.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1986, Volume: 104, Issue:11

    Topics: Absorption; Animals; Cell Line; Etanidazole; Eye; Eye Neoplasms; Female; Hypoxia; Nitroimidazoles; R

1986